BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential

Clinical trial NCT07416500 · COMPLETED

Trial details

NCT number: NCT07416500
Sponsor: Institute of Oncology Ljubljana
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Breast Lesions of Uncertain Malignant Potential (B3 Lesions)

Start date: 2024-09-01
Primary completion: 2025-06-30
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.